References
- Davie, M. (2015). Doing more for mental health. Archives of Disease in Childhood—Education & Practice Edition, 101(2), 77–81. doi:10.1136/archdischild-2015-308344
- McLaughlin, M., Kotis, D., Thomson, K., Harrison, M., Fennessy, G., Postelnick, M., & Scheetz, M. H. (2013). Effects on patient care caused by drug shortages: A survey. Journal of Managed Care Pharmacy, 19(9), 783–788. doi:10.18553/jmcp.2013.19.9.783
- Sunkel, C., & Viljoen, M. (2017). Shortage of psychiatric medications in South Africa. The Lancet Psychiatry, 4(1), 15–16. doi:10.1016/s2215-0366(16)30422-9
- Omorodion, J. O., Algahtani, R. M., Zocchi, M. S., Fox, E. R., Pines, J. M., & Kaminski, H. J. (2017). Shortage of generic neurologic therapeutics. Neurology, 89(24), 2431–2437. doi:10.1212/wnl.0000000000004737.
- Yazed Sulaiman Al-Ruthia, Wael Mansy, Mohammad Barasin, Yazeed Mohammad Ghawaa, Mohammed Al Sultan, Mohammad A. AlsenaidySolaiman Alhawas a, Sultan AlGhadeer (2017). Shortage of psychotropic medications in community pharmacies in Saudi Arabia: Causes and solutions Saudi Pharmaceutical Journal, 25, 744–749
- Desmarais, J. E., Beauclair, L., Margolese, H. C. (2011). Switching from brand-name to generic psychotropic medications: a literature review. CNS Neurosci Ther. 17(6): 750–60.
- Kluznik. J. C., Walbek, N. H., Farnsworth, M. G., et al. (2001). Clinical effects of a randomized switch of patients from clozaril to generic clozapine. J Clin Psychiatry, 62 (Suppl 5): 14–7
- Petrou, P., Vandoros, S. (2015). Cyprus in crisis: Recent changes in the pharmaceutical market and options for further reforms without sacrificing access or quality of treatment. Health Policy, 119(5), 563–568.
- Petrou, P., (2021) The 2019 introduction of the new National Healthcare System in Cyprus. Health Policy 125 (3), 284–289
https://www.eahp.eu/practice-and-policy/medicines-shortages - Al Ruthia, Y. S., Al Kofide, H., Al Ajmi, R., Balkhi, B., Alghamdi, A., Al Nasser, A., Alathbah, A. (2017). Drug shortages in large hospitals in Riyadh: a cross-sectional study. Annals of Saudi medicine, 37(5), 375–385. doi:10.5144/0256-4947.2017.375
- Gray, A., Manasse, H. R. (2012). Shortage of medicines: a complex global challenge. Bulletin of the World Health Organization 154–154A.
- Bochenek, T., Abilova, V., Alkan, A., Asanin, B., de Miguel Beriain, I., Besovic, Z., Vella Bonanno, P., Bucsics, A., Davidescu, M., De Weerdt, E., Duborija-Kovacevic, N., Fürst, J., Gaga, M., Gailīte, E., Gulbinovič, J., Gürpınar, E. U., Hankó, B., Hargaden, V., Hotvedt, T.A., Hoxha, I., Huys, I., Inotai, A., Jakupi, A., Jenzer, H., Joppi, R., Laius, O., Lenormand, M-C., Makridaki, D., Malaj, A., Margus, K., Marković-Peković, V., Miljković, N., de Miranda, J. L., Primožič, S., Rajinac, D., Schwartz, D. G., Šebesta, R., Simoens, S., Slaby, J., Sović-Brkičić, L,, Tesar, T., Tzimis, L., Warmińska, E. and Godman, B. (2018). Systemic measures and legislative and organizational frameworks aimed at preventing or mitigating drug shortages in 28 European and Western Asian countries. Front. Pharmacol. 8, 942. doi: 10.3389/fphar.2017.00942
- Finnish Medicines Agency. Helsinki: Finnish Medicines Agency; 2019.
www.fimea.fi/web/en/supervision/mandatory_reserve_supplies . Accessed 28 March 2019. - Weaver, J. M. (2010). Why are there so many drug shortages? Anesth Prog. 57, 89–90
- Petrou, P., Vandoros, S. (2018). Healthcare reforms in Cyprus 2013–2017: Does the crisis mark the end of the healthcare sector as we know it? Health Policy 122, 75–80